ILC Dover Announces North America Expansion to Meet Growing Demand

NEWARK, Del. – March 10, 2022 — ILC Dover LP (“ILC Dover” or the “Company”), specializing in innovative single-use and chemical workflow solutions for biotherapeutics and pharmaceutical processing, announced plans to significantly expand production capabilities in its Juarez, Mexico facility. This expansion is in response to the Company’s unprecedented growth in its life sciences business […]

ILC Dover Acquires KSE Scientific, a Leading Supplier of Water for Injection and Related Solutions for Biopharma, Cell & Gene Therapy, Tissue Banking and Medical Device End-Markets

Frederica, Delaware-  December 16, 2021 – ILC Dover, Inc. (“ILC Dover”, “ILC” or the “Company”), a leading designer and manufacturer of high-performance materials for life critical and primarily life sciences-based applications, today announced the acquisition of KSE Scientific (“KSE”), a sterile solutions manufacturer which specializes in the production of Water for Injection (WFI) and related […]

DoverPac® for HPAPI Transfers: Superior Powder Flow & Zero Cleaning

In a recent webinar, DoverPac® for HPAPI Transfers, ILC Dover discussed the two key benefits of DoverPac® technology: superior powder flow properties and zero cleaning. DoverPac® technology is a containment system that does a lot more than transfer powders. DoverPac® was purposely designed for ease of use in handling pharmaceutical products and should not be […]

[Webinar] DoverPac HPAPI Transfers: Zero Cleaning and Superior Powder Flow

This presentation of the DoverPac FIBC high containment system for transferring powders describes the unique capabilities in pharmaceutical processes. The DoverPac virtually eliminates cleaning resulting in cost savings and production time efficiencies. The benefits of the flexible wall technology is proven to be the best when filling and discharging poor flowing powders while promoting mass […]

Webinar: ILC Dover’s soloPURE™ Aseptic Isolator System

This webinar focuses on the development and advantages of ILC Dover’s aseptic flexible isolator system, soloPURE™. Presented by Martyn Ryder and Declan O’Shea, the session covers key topics such as the system’s design and benefits, its application in small-batch manufacturing and aseptic processing, and the advantages of single-use technologies. These advantages include faster market delivery, […]

[Whitepaper] ADC and Highly Potent Substance Containment

Solo Containment’s Martyn Ryder has been observing environmental monitoring systems from as early as 1989. It was clear from the start that segregation between operators and API powder was the key to reducing occupational exposure. In Ryder’s work, he grasped the importance of maintaining long-term and repeatable safety standards within the pharmaceutical sector. As a […]

[Whitepaper] Development of a Disposable Grade-A Aseptic Fill/Finish Isolation System

Isolation of aseptic processes is not a new technology. Rigid stainless-steel isolators have been available for decades, and flexible film isolation has been used in aseptic processing since the 1970s. Still, these systems tended to be a composite of stainless-steel chambers and airflow modules with a flexible film user interface. Solo Containment (now part of […]

Driving Expansion, ILC Dover Appoints New President in Pharmaceutical / Biopharmaceutical Business Unit

Frederica, Delaware, December 9, 2020 –  ILC Dover, a world leader in the design and production of single-use flexible solutions for pharmaceutical and biopharmaceutical manufacturing, today named David Radspinner as President of the Pharmaceutical/Biopharmaceutical Business Unit, effective December 14, 2020. In his new role, Dr. Radspinner is expected to contribute to ILC Dover’s continued growth by building and […]

ILC Dover Acquires Solo Containment, a Leading UK-Based Provider of Products Used in Pharmaceutical and Biopharmaceutical Manufacturing

Frederica, Delaware, September 9, 2020 – ILC Dover, Inc. (“ILC Dover” or the “Company”), a world leader in the design and production of single-use flexible solutions for pharmaceutical and biopharmaceutical manufacturing, today announced the acquisition of Solo Containment, Ltd. (“Solo”), a specialist manufacturer of flexible film isolators based in the United Kingdom. The acquisition will grow […]

Milling and Micronizing Pharmaceutical Powders in High Containment

The manufacturing of products within the micronized powders space is growing, especially for inhalation and injectable products. With particle sizes generally ranging from 2-20 microns, manufacturers face a huge challenge in terms of containing such small particles. Micronization is a common process in the pharma industry throughout the drug development cycle, from chemical synthesis to […]